-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12

Benzinga·05/15/2025 12:07:18
Listen to the news
Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:MGX) with a Buy and lowers the price target from $13 to $12.